Mazvita Muchengeti to Sarcoma, Kaposi
This is a "connection" page, showing publications Mazvita Muchengeti has written about Sarcoma, Kaposi.
Connection Strength
2,512
-
Cohort profile: the South African HIV Cancer Match (SAM) Study, a national population-based cohort. BMJ Open. 2022 04 11; 12(4):e053460.
Score: 0,778
-
Cancer in HIV-positive and HIV-negative adolescents and young adults in South Africa: a cross-sectional study. BMJ Open. 2021 10 18; 11(10):e043941.
Score: 0,753
-
Age and Cancer Incidence in 5.2 Million People With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study. Clin Infect Dis. 2023 04 17; 76(8):1440-1448.
Score: 0,209
-
Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout. Int J Cancer. 2023 05 15; 152(10):2081-2089.
Score: 0,206
-
Epidemiology of Kaposi's sarcoma in sub-Saharan Africa. Cancer Epidemiol. 2022 Jun; 78:102167.
Score: 0,195
-
Lifestyle factors associated with sex differences in Kaposi sarcoma incidence among adult black South Africans: A case-control study. Cancer Epidemiol. 2022 Jun; 78:102158.
Score: 0,195
-
The impact of the South African antiretroviral treatment programme on the age-standardised incidence rate of Kaposi sarcoma, 1999-2016: An interrupted time series analysis. Int J Infect Dis. 2021 Jan; 102:20-27.
Score: 0,175